Literature DB >> 25195847

Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.

Ivan Milenkovic1, Tatjana Petrov, Gabor G Kovacs.   

Abstract

BACKGROUND/AIMS: Deposits of phosphorylated tau protein and convergence of pathology in the hippocampus are the hallmarks of neurodegenerative tauopathies. Thus we aimed to evaluate whether regional and cellular vulnerability patterns in the hippocampus distinguish tauopathies or are influenced by their concomitant presence.
METHODS: We created a heat map of phospho-tau (AT8) immunoreactivity patterns in 24 hippocampal subregions/layers in individuals with Alzheimer's disease (AD)-related neurofibrillary degeneration (n = 40), Pick's disease (n = 8), progressive supranuclear palsy (n = 7), corticobasal degeneration (n = 6), argyrophilic grain disease (AGD, n = 18), globular glial tauopathy (n = 5), and tau-astrogliopathy of the elderly (n = 10). AT8 immunoreactivity patterns were compared by mathematical analysis.
RESULTS: Our study reveals disease-specific hot spots and regional selective vulnerability for these disorders. The pattern of hippocampal AD-related tau pathology is strongly influenced by concomitant AGD. Mathematical analysis reveals that hippocampal involvement in primary tauopathies is distinguishable from early-stage AD-related neurofibrillary degeneration.
CONCLUSION: Our data demonstrate disease-specific AT8 immunoreactivity patterns and hot spots in the hippocampus even in tauopathies, which primarily do not affect the hippocampus. These hot spots can be shifted to other regions by the co-occurrence of tauopathies like AGD. Our observations support the notion that globular glial tauopathies and tau-astrogliopathy of the elderly are distinct entities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25195847     DOI: 10.1159/000365548

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  14 in total

1.  Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.

Authors:  Gabor G Kovacs; Linda K Kwong; Murray Grossman; David J Irwin; Edward B Lee; John L Robinson; Eunran Suh; Vivianna M Van Deerlin; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-01-19       Impact factor: 6.508

Review 2.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

3.  Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy.

Authors:  Kurt Farrell; Megan A Iida; Jonathan D Cherry; Alicia Casella; Thor D Stein; Kevin F Bieniek; Jamie M Walker; Timothy E Richardson; Charles L White; Victor E Alvarez; Bertrand R Huber; Dennis W Dickson; Ricardo Insausti; Kristen Dams-O'Connor; Ann C McKee; John F Crary
Journal:  J Neuropathol Exp Neurol       Date:  2022-09-19       Impact factor: 3.148

Review 4.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

5.  Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease.

Authors:  Jamie M Walker; Yelena Fudym; Kurt Farrell; Megan A Iida; Kevin F Bieniek; Sudha Seshadri; Charles L White; John F Crary; Timothy E Richardson
Journal:  J Neuropathol Exp Neurol       Date:  2021-04-16       Impact factor: 3.685

6.  Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.

Authors:  Jonathan D Cherry; Camille D Esnault; Zachary H Baucom; Yorghos Tripodis; Bertrand R Huber; Victor E Alvarez; Thor D Stein; Dennis W Dickson; Ann C McKee
Journal:  Acta Neuropathol Commun       Date:  2021-05-12       Impact factor: 7.578

7.  Clinical Neuropathology image 6-2014: Corpora amylacea replacing cornu ammonis (CACA).

Authors:  Gabor G Kovacs; Daniele Risser
Journal:  Clin Neuropathol       Date:  2014 Nov-Dec       Impact factor: 1.368

Review 8.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

9.  Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.

Authors:  Jamie M Walker; Timothy E Richardson; Kurt Farrell; Megan A Iida; Chan Foong; Ping Shang; Johannes Attems; Gai Ayalon; Thomas G Beach; Eileen H Bigio; Andrew Budson; Nigel J Cairns; María Corrada; Etty Cortes; Dennis W Dickson; Peter Fischer; Margaret E Flanagan; Erin Franklin; Marla Gearing; Jonathan Glass; Lawrence A Hansen; Vahram Haroutunian; Patrick R Hof; Lawrence Honig; Claudia Kawas; C Dirk Keene; Julia Kofler; Gabor G Kovacs; Edward B Lee; Mirjam I Lutz; Qinwen Mao; Eliezer Masliah; Ann C McKee; Corey T McMillan; M Marsel Mesulam; Melissa Murray; Peter T Nelson; Richard Perrin; Thao Pham; Wayne Poon; Dushyant P Purohit; Robert A Rissman; Kenji Sakai; Mary Sano; Julie A Schneider; Thor D Stein; Andrew F Teich; John Q Trojanowski; Juan C Troncoso; Jean-Paul Vonsattel; Sandra Weintraub; David A Wolk; Randall L Woltjer; Masahito Yamada; Lei Yu; Charles L White; John F Crary
Journal:  J Neuropathol Exp Neurol       Date:  2021-01-20       Impact factor: 3.148

Review 10.  Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.

Authors:  Stephen P Arnerić; Richard Batrla-Utermann; Laurel Beckett; Tobias Bittner; Kaj Blennow; Leslie Carter; Robert Dean; Sebastiaan Engelborghs; Just Genius; Mark Forrest Gordon; Janice Hitchcock; June Kaplow; Johan Luthman; Richard Meibach; David Raunig; Klaus Romero; Mahesh N Samtani; Mary Savage; Leslie Shaw; Diane Stephenson; Robert M Umek; Hugo Vanderstichele; Brian Willis; Susan Yule
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.